Frequently Asked Questions
The market is segmented based on , By Type (Osmotic laxatives, Stimulant laxatives, Bulk laxatives and Lubricant and Emollient laxatives), Flavors (With Flavor and Without Flavor), Source (Natural, Synthetic and Others), Indication (Chronic Constipation, irritable bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation and Others), Mode of Purchase (Prescription and Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories and Others), Route of Administration (Oral and Rectal), Population Type (Children and Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, grocery/Health and Beauty Stores and Others), Distribution channel (Direct Sales, Wholesalers and Others) – Industry Trends and Forecast to 2031.
.
The North America Laxative Market size was valued at USD 4.31 USD Billion in 2023.
The North America Laxative Market is projected to grow at a CAGR of 5.7% during the forecast period of 2024 to 2031.
The major players operating in the market include Boehringer Ingelheim International GmbH , GlaxoSmithKline plc , Bayer AG , Fresenius Kabi Austria GmbH , Prestige Consumer Healthcare , Procter & Gamble , Sun Pharmaceutical Industries Ltd , Sanofi Aventis LLC U.S , RECORDATI , Mall,krodt , Hikma Pharmaceuticals PLC , Abbott , Avrio Health L.P , Dr Reddy’s Laboratories Ltd , LNK INTERNATIONAL , Cipla , Aspen Pharmacare Australia Pty Ltd , Salix PHARMACEUTICAL , Torrent Pharmaceuticals Ltd .
The market report covers data from the U.S., Canada, and Mexico.
